Iterum Therapeutics plc Recorded Big Gain
Fri, May 28, 2021 at 05:30 PM
Iterum Therapeutics plc (ITRM:NASDAQ) rocketted at $1.45, representing a gain of 17.9%. On Thu, May 27, 2021, ITRM:NASDAQ touched a New 2-Week High of $1.23. The stock appeared on our News Catalysts scanner on Fri, May 28, 2021 at 04:37 PM in the 'MISCELLANEOUS' category. From Thu, May 13, 2021, the stock recorded 70.00% Up Days and 54.55% Green Days
The stock spiked on Thu, Feb 11, 2021 at $3 with a volume of 95M+, and its share price has been moving sideways in recent weeks.
About Iterum Therapeutics plc (ITRM:NASDAQ)
Iterum Therapeutics PLC is a clinical-stage pharmaceutical company. The company is engaged in developing and commercializing sulopenem to be the first and only oral and intravenous branded penem available globally.
Top 10 Gainers:
- Vertex Energy, Inc. (VTNR:NASDAQ), 95.74%
- eMagin Corporation (EMAN:NYSEMKT), 53.01%
- SemiLEDs Corporation (LEDS:NASDAQ), 44.86%
- Mannatech, Incorporated (MTEX:NASDAQ), 26.07%
- Lianluo Smart Limited (LLIT:NASDAQ), 24.59%
- Welbilt, Inc. (WBT:NYSE), 24.05%
- Organovo Holdings, Inc. (ONVO:NASDAQ), 20.82%
- SRGA (SRGA:NASDAQ), 18.07%
- Iterum Therapeutics plc (ITRM:NASDAQ), 17.89%
- WRAP (WRAP:NASDAQ), 17.59%